Hybrid <i>In Silico</i> and TR-FRET-Guided Discovery of Novel BCL-2 Inhibitors.

Sahin, Kader; Orhan, Muge Didem; Avsar, Timucin; Durdagi, Serdar

Hybrid In Silico and TR-FRET-Guided Discovery of Novel BCL-2 Inhibitors.

Sahin, Kader; Orhan, Muge Didem; Avsar, Timucin; Durdagi, Serdar.

Afiliación

Sahin K; Computational Biology and Molecular Simulations Laboratory, Department of Biophysics, School of Medicine, Bahcesehir University, Istanbul 34353, Turkey.
Orhan MD; Neuroscience Program, Health Sciences Institute, Bahcesehir University, Istanbul 34353, Turkey.
Avsar T; Neuroscience Laboratory, Health Sciences Institute, Bahcesehir University, Istanbul 34353, Turkey.
Durdagi S; Neuroscience Program, Health Sciences Institute, Bahcesehir University, Istanbul 34353, Turkey.

ACS Pharmacol Transl Sci ; 4(3): 1111-1123, 2021 Jun 11.

Article en En | MEDLINE | ID: mdl-34151203

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Guideline / Prognostic_studies Idioma: En Revista: ACS Pharmacol Transl Sci Año: 2021 Tipo del documento: Article País de afiliación: Turquía

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google